AUG 08, 2017 3:15 PM PDT

Detecting Glaucoma Years in Advance

WRITTEN BY: Xuan Pham

Image credit: Pixabay.com

In an effort to detect and prevent glaucoma-associated blindness, scientists say they’ve developed a test that can pick up glaucoma up to four years earlier than conventional methods. With more clinical trials being planned, researchers hope the diagnostic test will prevent, or at least slow down, vision loss associated with glaucoma worldwide.
 

"Glaucoma is one of the leading causes of irreversible blindness in the world, and in the early stages patients usually have no symptoms and are not aware they are developing permanent vision loss," said Michael Kalloniatis, Director of the University of New South Wales (UNSW) Center for Eye Health, and co-designer of the new visual test.
 
Commonly, glaucoma results when the eye’s fluid pressure builds up, which causes damage to the optic nerve that’s located at the back of the eye. The change usually happens gradually and without pain, so many people who have glaucoma symptoms may not be aware that their vision is at risk. As such, glaucoma often described as a disease that steals vision without warning. In the United States alone, the Glaucoma Research Foundation estimates over 3 million Americans have glaucoma.
 
"The cause of the disease is unknown and there is no cure, but its progression can be slowed with eye drops or surgery to lower pressure in the eye. So, early detection and early treatment is vital for prolonging sight," said Kalloniatis.
 
The new glaucoma test is a computerized system that analyzes a patient’s visual field. Patients are asked to look at many dots of light that vary in size and brightness. The inability to see certain dots indicates blind spots in the eye and a potential loss of peripheral vision, which is mainly affected by glaucoma.
 


Traditional methods to assess glaucoma risks often rely on physical measurements of the eye. This includes assessing the intraocular pressure, the optic nerve, and other exams of the eye itself. However, because glaucoma symptoms are gradual, these types of tests are not sensitive enough to pick up glaucoma before the condition worsens. Furthermore, because eye pressure may change throughout the day, these types of measurements can be unreliable.
 
Aside from the physical eye exams, doctors also use a visual field test (called the Visual Field Analyzer), but the researchers criticized this test for its limitations. "The current method of visual field testing, which uses just one dot size, is good but not ideal. Our test appears to be much more sensitive at detecting disease in an early stage. On average, we expect we will be able to detect glaucoma four years earlier than at present," said Kalloniatis.
 
In comparing the new visual test to standard methods in 13 patients, the team reported their test was superior at detecting vision loss. They are ramping up to include up to 30 more patients in the next clinical trial. In the meantime, Kalloniatis and co-author Siu Khuu, have patented their system in the US and the European Union.

"We hope our new approach will eventually be introduced around the world, and treatment can begin earlier to slow down vision loss in glaucoma," said Kalloniatis.

Additional source: University of New South Wales, Bel Mara Health

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
OCT 29, 2020
Clinical & Molecular DX
Skin Deep: A Novel Test for Parkinson's
OCT 29, 2020
Skin Deep: A Novel Test for Parkinson's
In Parkinson’s disease (PD), there is chronic degeneration of the central nervous system, particularly in the regi ...
NOV 07, 2020
Neuroscience
Device Measures Stress Hormones with Earwax
NOV 07, 2020
Device Measures Stress Hormones with Earwax
Researchers from University College London and King’s College London in the UK have developed a device that can me ...
DEC 02, 2020
Cancer
Investigating the Active Components of an Herbal Mushroom
DEC 02, 2020
Investigating the Active Components of an Herbal Mushroom
When people think of traditional medicine, often what comes to mind are the old herbal medical practices in Asian countr ...
DEC 23, 2020
Cancer
A Combination of Photo and Sonodynamic Therapies Could Assist in Treating Brain Cancer
DEC 23, 2020
A Combination of Photo and Sonodynamic Therapies Could Assist in Treating Brain Cancer
Brain cancer is an incredible challenge for modern medicine. Most drugs don’t make it past the blood-brain barrier ...
JAN 13, 2021
Clinical & Molecular DX
E-Stethoscope Picks up Good (and Bad) Vibrations
JAN 13, 2021
E-Stethoscope Picks up Good (and Bad) Vibrations
A medical device used to survey lung sounds to monitor for signs of respiratory distress has received FDA clearance. RES ...
FEB 02, 2021
Clinical & Molecular DX
Keeping an Eye on COVID Clusters With Rapid Sequencing
FEB 02, 2021
Keeping an Eye on COVID Clusters With Rapid Sequencing
Contact tracing is a powerful tool used by public health authorities to help slow the spread of infectious diseases such ...
Loading Comments...